Mast cells and basophils

Atopic Dermatitis

Volumn , Issue , 2002, Pages 285-326

  Kambe, Naotomo ^a   Irani, Anne Marie ^a   Schwartz, Lawrence B ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34250632517     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (217)

1. EB Mitchell, J Crow, G Williams, TA Platts-Mills. Increase in skin mast cells following chronic house dust mite exposure. Br J Dermatol 114:65-73, 1986.
2. M Mihm Jr, N Soter, H Dvorak, KF Austen. The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 67:305-312, 1976.
3. AA Irani, HA Sampson, LB Schwartz. Mast cells in atopic dermatitis. Allergy 44 (suppl 9):31-34, 1989.
4. A Järvikallio, A Naukkarinen, IT Harvima, ML Aalto, M Horsmanheimo. Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema. Br J Dermatol 136:871-877, 1997.
5. TE Damsgaard, AB Olesen, FB Sorensen, K Thestrup-Pedersen, PO Schiotz. Mast cells and atopic dermatitis. Stereological quantification of mast cells in atopic dermatitis and normal human skin. Arch Dermatol Res 289:256-260, 1997.
6. AJ Sandford, T Shirakawa, MF Moffatt, SE Daniels, C Ra, JA Faux, RP Young, Y Nakamura, GM Lathrop, WO Cookson. Localisation of atopy and beta subunit of high-affinity IgE receptor (Fc epsilon RI) on chromosome 11q [see comments]. Lancet 341:332-334, 1993.
7. T Shirakawa, A Li, M Dubowitz, JW Dekker, AE Shaw, JA Faux, C Ra, WO Cookson, JM Hopkin. Association between atopy and variants of the beta subunit of the high-affinity immunoglobulin E receptor [see comments]. Nat Genet 7:125-129, 1994.
8. R Coleman, RC Trembath, JI Harper. Chromosome 11q13 and atopy underlying atopic eczema. Lancet 341:1121-1122, 1993.
9. HE Cox, MF Moffatt, JA Faux, AJ Walley, R Coleman, RC Trembath, WO Cook-son, JI Harper. Association of atopic dermatitis to the beta subunit of the high affinity immunoglobulin E receptor [see comments]. Br J Dermatol 138:182-187, 1998.
10. XQ Mao, T Shirakawa, T Yoshikawa, K Yoshikawa, M Kawai, S Sasaki, T Eno-moto, T Hashimoto, J Furuyama, JM Hopkin, K Morimoto. Association between genetic variants of mast-cell chymase and eczema [see comments] [published erratum appears in Lancet 349(9044):64, 1997]. Lancet 348:581-583, 1996.
11. XQ Mao, T Shirakawa, T Enomoto, S Shimazu, Y Dake, H Kitano, A Hagihara, JM Hopkin. Association between variants of mast cell chymase gene and serum IgE levels in eczema [published erratum appears in Human Hered 48(2):91, 1998]. Human Heredity 48:38-41, 1998.
12. K Tanaka, H Sugiura, M Uehara, H Sato, T Hashimoto-Tamaoki, J Furuyama.Association between mast cell chymase genotype and atopic eczema: comparison between patients with atopic eczema alone and those with atopic eczema and atopic respiratory disease. Clin Exp Allergy 29:800-803, 1999.
13. Y Kitamura, M Shimada, K Hatanaka, Y Miyano. Development of mast cells from grafted bone marrow cells in irradiated mice. Nature 268:442-443, 1977.
14. S Hasthorpe. A hemopoietic cell line dependent upon a factor in pokeweed mitogen-stimulated spleen cell conditioning medium. J Cell Physiol 105:379-384, 1980.
15. GJ Nabel, SJ Galli, AM Dvorak, HF Dvorak, H Cantor. Inducer T lymphocytes synthesize a factor that stimulates proliferation of cloned mast cells. Nature 291: 332-334, 1981.
16. K Nagao, K Yokoro, SA Aaronson. Continuous lines of basophil mast cells derived from normal mouse bone marrow. Science 212:333-335, 1981.
17. JW Schrader, SJ Lewis, I Clark-Lewis, JG Culvenor. The persisting (P) cell: histamine content, regulation by a T cell-derived factor, origin from a bone marrow precursor, and relationship to mast cells. Proc Natl Acad Sci USA 78:323-327, 1981.
18. YP Yung, R Eger, G Tertian, MA Moore. Long-term in vitro culture of murine mast cells. II. Purification of a mast cell growth factor and its dissociation from TCGF. J Immunol 127:794-799, 1981.
19. JN Ihle, JR Keller, S Oroszlan, LE Henderson, TD Copeland, FW Fitch, MB Prys-towsky, E Goldwasser, JW Schrader, EW Palaszynski, M Dy, B Lebel. Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell- stimulating factor activity. J Immunol 131:282-287, 1983.
20. T Yokota, F Lee, D Rennick, C Hall, N Arai, T Mosmann, G Nabel, H Cantor, K Arai. Isolation and characterization of a mouse cDNA clone that expresses mastcell growth- factor activity in monkey cells. Proc Natl Acad Sci USA 81:1070-1074, 1984.
21. EJ Ruitenberg, A Elgersma. Absence of intestinal mast cell response in congenitally athymic mice during Trichinella spiralis infection. Nature 264:258-260, 1976.
22. CS Lantz, J Boesiger, CH Song, N Mach, T Kobayashi, RC Mulligan, Y Nawa, G Dranoff, SJ Galli. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 392:90-93, 1998.
23. v mice and their increase by bone marrow transplantation. Blood 52:447-452, 1978.
24. d anemic mice. Blood53:492-497, 1979.
25. J Wedemeyer, M Tsai, SJ Galli. Roles of mast cells and basophils in innate and acquired immunity. Curr Opin Immunol 12:624-631, 2000.
26. AA Irani, G Nilsson, U Miettinen, SC Craig, LK Ashman, T Ishizaka, KM Zsebo, LB Schwartz. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 80:3009-3021, 1992.
27. H Mitsui, T Furitsu, AM Dvorak, AA Irani, LB Schwartz, N Inagaki, M Takei, K Ishizaka, KM Zsebo, S Gillis, T Ishizaka. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc Natl Acad Sci USA 90:735-739, 1993.
28. P Valent, E Spanblochl, WR Sperr, C Sillaber, KM Zsebo, H Agis, H Strobl, K Geissler, P Bettelheim, K Lechner. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kif-ligand in long-term culture. Blood 80:2237-2245, 1992.
29. +/ Fce RU cell population. Blood 84:2489-2496, 1994.
30. D Kempuraj, H Saito, A Kaneko, K Fukagawa, M Nakayama, H Toru, M Tomi-kawa, H Tachimoto, M Ebisawa, A Akasawa, T Miyagi, H Kimura, T Nakajima, K Tsuji, T Nakahata. Characterization of mast cell-committed progenitors present in human umbilical cord blood. Blood 93:3338-3346, 1999.
31. AS Kirshenbaum, JP Goff, T Semere, B Foster, LM Scott, DD Metcalfe. Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood 94:2333-2342, 1999.
32. LW Terstappen, S Huang, M Safford, PM Lansdorp, MR Loken. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. Blood 77:1218-1227, 1991.
33. CI Civin. Human monomyeloid cell membrane antigens. Exp Hematol 18:461-467, 1990.
34. ZM Du, YL Li, HZ Xia, AM Irani, LB Schwartz. Recombinant human granulocyte-macrophage colony-stimulating factor (CSF), but not recombinant human granulocyte CSF, down- regulates the recombinant human stem cell factor-dependent differentiation of human fetal liver-derived mast cells. J Immunol 159:838-845, 1997.
35. CA Oskeritzian, Z Wang, JP Kochan, M Grimes, Z Du, HW Chang, S Grant, LB Schwartz. Recombinant human (rh)IL-4-mediated apoptosis and recombinant human IL-6-mediated protection of recombinant human stem cell factor-dependent human mast cells derived from cord blood mononuclear cell progenitors. J Immunol163:5105-5115, 1999.
36. 2 from cord blood mononuclear cells. J Immunol 157:343-350, 1996.
37. N Kambe, M Kambe, HW Chang, A Matsui, HK Min, M Hussein, CA Oskerizian, J Kochan, AMA Irani, LB Schwartz. An improved procedure for the development of human mast cells from dispersed fetal liver cells in serum-free culture medium. J Immunol Meth 240:101-110, 2000.
38. G Nilsson, U Miettinen, T Ishizaka, LK Ashman, AM Irani, LB Schwartz. Interleukin-4 inhibits the expression of Kit and tryptase during stem cell factor-dependent development of human mast cells from fetal liver cells. Blood 84:1519-1527, 1994.
39. H Nagata, AS Worobec, CK Oh, S Tannenbaum, Y Suzuki, DD Metcalfe. Identification of a point mutation in the catalytic domain of the proto-oncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 92:10560-10564, 1995.
40. BJ Longley Jr., DD Metcalfe, M Tharp, XM Wang, L Tyrrell, SZ Lu, D Heitjan, YS Ma. Activating and dominant inactivating c-kit catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci USA 96:1609-1614, 1999.
41. S Hirota, K Isozaki, Y Moriyama, K Hashimoto, T Nishida, S Ishiguro, K Kawano, M Hanada, A Kurata, M Takeda, GM Tunio, Y Matsuzawa, Y Kanakura, Y Shino-mura, Y Kitamura. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577-580, 1998.
42. C Sillaber, H Strobl, D Bevec, LK Ashman, JH Butterfield, K Lechner, D Maurer, P Bettelheim, P Valent. IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells. J Immunol 147:4224-4228, 1991.
43. HZ Xia, ZM Du, S Craig, G Klisch, N Noben-Trauth, JP Kochan, TH Huff, AM Irani, LB Schwartz. Effect of recombinant human IL-4 on tryptase, chymase, and Fce receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells. J Immunol 159:2911-2921, 1997.
44. H Toru, C Ra, S Nonoyama, K Suzuki, J Yata, T Nakahata. Induction of the high-affinity IgE receptor (FceRI) on human mast cells by IL-4. International Immunology 8:1367-1373, 1996.
45. SC Bischoff, G Sellge, A Lorentz, W Sebald, R Raab, MP Manns. IL-4 enhances proliferation and mediator release in mature human mast cells. Proc Natl Acad Sci USA 96:8080-8085, 1999.
46. M Yanagida, H Fukamachi, K Ohgami, T Kuwaki, H Ishii, H Uzumaki, K Amano, T Tokiwa, H Mitsui, H Saito, Y Iikura, T Ishizaka, T Nakahata. Effects of T-helper 2-type cytokines, interleukin-3 (IL- 3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells. Blood 86:3705-3714, 1995.
47. H Toru, T Kinashi, C Ra, S Nonoyama, J Yata, T Nakahata. Interleukin-4 induces homotypic aggregation of human mast cells by promoting LFA-1/ICAM-1 adhesion molecules. Blood 89:3296-3302, 1997.
48. G Nilsson, K Nilsson. Effects of interleukin (IL)-13 on immediate-early response gene expression, phenotype and differentiation of human mast cells. Comparison with IL-4. Eur J Immunol 25:870-873, 1995.
49. T Kinoshita, N Sawai, E Hidaka, T Yamashita, K Koike. Interleukin-6 directly modulates stem cell factor-dependent development of human mast cells derived from CD34(+) cord blood cells. Blood 94:496-508, 1999.
50. L Thompson-Snipes, V Dhar, MW Bond, TR Mosmann, KW Moore, DM Rennick.Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J Exp Med 173:507-510, 1991.
51. N Ghildyal, DS Friend, CF Nicodemus, KF Austen, RL Stevens. Reversible expression of mouse mast cell protease 2 mRNA and protein in cultured mast cells exposed to IL-10. J Immunol 151:3206-3214, 1993.
52. N Ghildyal, HP McNeil, MF Gurish, KF Austen, RL Stevens. Transcriptional regulation of the mucosal mast cell-specific protease gene, MMCP-2, by interleukin 10 and interleukin 3. J Biol Chem 267:8473-8477, 1992.
53. N Ghildyal, HP McNeil, S Stechschulte, KF Austen, D Silberstein, MF Gurish, LL Somerville, RL Stevens. IL-10 induces transcription of the gene for mouse mast cell protease-1, a serine protease preferentially expressed in mucosal mast cells of Trichinella spiralis-infected mice. J Immunol 149:2123-2129, 1992.
54. M Kambe, N Kambe, C Oskeritzian, NM Schechter, LB Schwartz. IL-6 attenuates apoptosis, while neither IL-6 nor IL-10 affect the numbers or protease phenotype of fetal liver-derived human mast cells. Clin Exp Allergy 31:1077-1085, 2001.
55. AA Irani, NM Schechter, SS Craig, G DeBlois, LB Schwartz. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 83:4464-4468, 1986.
56. AM Irani, SS Craig, G DeBlois, CO Elson, NM Schechter, LB Schwartz. Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function. J Immunol 138:4381-4386, 1987.
57. Y Kanakura, H Thompson, T Nakano, T Yamamura, H Asai, Y Kitamura, DD Metcalfe, SJ Galli. Multiple bidirectional alterations of phenotype and changes in proliferative potential during the in vitro and in vivo passage of clonal mast cell populations derived from mouse peritoneal mast cells. Blood 72:877-885, 1988.
58. v mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J Exp Med 162:1025-1043, 1985.
59. F Levi-Schaffer, KF Austen, PM Gravallese, RL Stevens. Coculture of interleukin 3-dependent mouse mast cells with fibroblasts results in a phenotypic change of the mast cells [published erratum appears in Proc Natl Acad Sci USA 83(20):7805, 1986]. Proc Natl Acad Sci USA 83:6485-6488, 1986.
60. M Tsai, LS Shih, GF Newlands, T Takeishi, KE Langley, KM Zsebo, HR Miller, EN Geissler, SJ Galli. The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype. J Exp Med 174:125-131, 1991.
61. d genetically mast cell-deficient mice. Blood 75:1637-1645, 1990.
62. H Matsuda, Y Kannan, H Ushio, Y Kiso, T Kanemoto, H Suzuki, Y Kitamura.Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells. J Exp Med 174:7-14, 1991.
63. H Toru, M Eguchi, R Matsumoto, M Yanagida, J Yata, T Nakahata. Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation. Blood 91:187-195, 1998.
64. SY Tam, M Tsai, M Yamaguchi, K Yano, JH Butterfield, SJ Galli. Expression of functional TrkA receptor tyrosine kinase in the HMC-1 human mast cell line and in human mast cells. Blood 90:1807-1820, 1997.
65. SS Craig, NM Schechter, LB Schwartz. Ultrastructural analysis of maturing human T and TC mast cells in situ. Lab Invest 60:147-157, 1989.
66. G Nilsson, JA Mikovits, DD Metcalfe, DD Taub. Mast cell migratory response to interleukin-8 is mediated through interaction with chemokine receptor CXCR2/interleukin-8RB. Blood 93:2791-2797, 1999.
67. H Ochi, WM Hirani, Q Yuan, DS Friend, KF Austen, JA Boyce. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J Exp Med 190:267-280, 1999.
68. P Romagnani, A De Paulis, C Beltrame, F Annunziato, V Dente, E Maggi, S Ro-magnani, G Marone. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. Am J Pathol 155:1195-1204, 1999.
69. K Yamauchi, R Sato, Y Tanno, Y Ohkawara, K Maeyama, T Watanabe, K Satoh, M Yoshizawa, S Shibahara, T Takishima. Nucleotide sequence of the cDNA encoding L-histidine decarboxylase derived from human basophilic leukemia cell line, KU-812- F. Nucleic Acids Res 18:5891-5891, 1990.
70. I Gantz, M Schaffer, J DelValle, C Logsdon, V Campbell, M Uhler, T Yamada.Molecular cloning of a gene encoding the histamine H2 receptor [published erratum appears in Proc Natl Acad Sci USA 88(13):5937, 1991]. Proc Natl Acad Sci USA 88:429-433, 1991.
71. H Asako, I Kurose, R Wolf, S DeFrees, ZL Zheng, ML Phillips, JC Paulson, DN Granger. Role of H1 receptors and P-selectin in histamine-induced leukocyte rolling and adhesion in postcapillary venules. J Clin Invest 93:1508-1515, 1994.
72. P Kubes, S Kanwar. Histamine induces leukocyte rolling in post-capillary venules. A P-selectin-mediated event. J Immunol 152:3570-3577, 1994.
73. I Inoue, K Yanai, D Kitamura, I Taniuchi, T Kobayashi, K Niimura, T Watanabe, T Watanabe. Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors. Proc Natl Acad Sci USA 93:13316-13320, 1996.
74. I Robertson, MW Greaves. Responses of human skin blood vessels to synthetic histamine analogues. Br J Clin Pharmacol 5:319-1978.
75. M Kaliner, JH Shelhamer, EA Ottesen. Effects of infused histamine: correlation of plasma histamine levels and symptoms. J Allergy Clin Immunol 69:283-289, 1982.
76. T types by labeling with antithrombin III-gold. Lab Invest 69:552-561, 1993.
77. SE Stringer, M Mayer-Proschel, A Kalyani, M Rao, JT Gallagher. Heparin is a unique marker of progenitors in the glial cell lineage. J Biol Chem 274:25455-25460, 1999.
78. JA Reed, AP Albino, NS McNutt. Human cutaneous mast cells express basic fibroblast growth factor. Lab Invest 72:215-222, 1995.
79. RM Nelson, O Cecconi, WG Roberts, A Aruffo, RJ Linhardt, MP Bevilacqua. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation. Blood82:3253-3258, 1993.
80. E Forsberg, G Pejler, M Ringvall, C Lunderius, B Tomasini-Johansson, M Kusche-Gullberg, I Eriksson, J Ledin, L Hellman, L Kjellen. Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature 400:773-776, 1999.
81. DE Humphries, GW Wong, DS Friend, MF Gurish, WT Qiu, CF Huang, AH Sharpe, RL Stevens. Heparin is essential for the storage of specific granule proteases in mast cells. Nature 400:769-772, 1999.
82. H Chiu, D Lagunoff. Histochemical comparison of vertebrate mast cells. Histochem J 4:135-144, 1972.
83. GC Glenner, LA Cohen. Histochemical demonstration of species-specific trypsinlike enzyme in mast cells. Nature (London) 185:846-847, 1960.
84. VK Hopsu, GG Glenner. A histochemical enzyme kinetic system applied to the trypsin-like amidase and esterase activity in human mast cells. J Cell Biol 17:503-510, 1963.
85. LB Schwartz, RA Lewis, D Seldin, KF Austen. Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. J Immunol 126:1290-1294, 1981.
86. LB Schwartz, RA Lewis, KF Austen. Tryptase from human pulmonary mast cells. Purification and characterization. J Biol Chem 256:11939-11943, 1981.
87. SC Alter, DD Metcalfe, TR Bradford, LB Schwartz. Regulation of human mast cell tryptase. Effects of enzyme concentration, ionic strength and the structure and negative charge density of polysaccharides. Biochem J 248:821-827, 1987.
88. LB Schwartz, TR Bradford. Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer. J Biol Chem 261:7372-7379, 1986.
89. PJ Pereira, A Bergner, S Macedo-Ribeiro, R Huber, G Matschiner, H Fritz, CP Sommerhoff, W Bode. Human P-tryptase is a ring-like tetramer with active sites facing a central pore. Nature 392:306-311, 1998.
90. SC Alter, JA Kramps, A Janoff, LB Schwartz. Interactions of human mast cell tryptase with biological protease inhibitors. Arch Biochem Biophys 276:26-31, 1990.
91. JS Miller, EH Westin, LB Schwartz. Cloning and characterization of complementary DNA for human tryptase. J Clin Invest 84:1188-1195, 1989.
92. JS Miller, G Moxley, LB Schwartz. Cloning and characterization of a second complementary DNA for human tryptase. J Clin Invest 86:864-870, 1990.
93. P Vanderslice, SM Ballinger, EK Tam, SM Goldstein, CS Craik, GH Caughey.Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family. Proc Natl Acad Sci USA 87:3811-3815, 1990.
94. M Pallaoro, MS Fejzo, L Shayesteh, JL Blount, GH Caughey. Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3. J Biol Chem 274:3355-3362, 1999.
95. HP McNeil, DS Reynolds, V Schiller, N Ghildyal, DS Gurley, KF Austen, RL Stevens. Isolation, characterization, and transcription of the gene encoding mouse mast cell protease 7. Proc Natl Acad Sci USA 89:11174-11178, 1992.
96. DS Reynolds, DS Gurley, KF Austen, WE Serafin. Cloning of the cDNA and gene of mouse mast cell protease-6. Transcription by progenitor mast cells and mast cells of the connective tissue subclass. J Biol Chem 266:3847-3853, 1991.
97. GH Caughey. Mast cell chymases and tryptases: phylogeny, family relations, and biogenesis. In: GH Caughey, ed. Mast Cell Proteases in Immunology and Biology. New York: Marcel Dekker, Inc., 1995, pp 305-329.
98. E Baker, TJ Sayers, GR Sutherland, MJ Smyth. The genes encoding NK cell granule serine proteases, human tryptase-2 (TRYP2) and human granzyme A (HFSP), both map to chromosome 5q11-q12 and define a new locus for cytotoxic lymphocyte granule tryptases. Immunogenetics 40:235-237, 1994.
99. D Hudig, NJ Allison, CM Kam, JC Powers. Selective isocoumarin serine protease inhibitors block RNK-16 lymphocyte granule-mediated cytolysis. Mol Immunol26:793-798, 1989.
100. TJ Sayers, AR Lloyd, DW McVicar, MD O’Connor, JM Kelly, CRD Carter, TA Wiltrout, RH Wiltrout, MJ Smyth. Cloning and expression of a second human natural killer cell granule tryptase, HNK-Tryp-2/granzyme 3. J Leuk Biol 59:763-768, 1996.
101. H Kido, A Fukutomi, N Katunuma. A novel membrane-bound serine esterase in human T4+ lymphocytes immunologically reactive with antibody inhibiting syncytia induced by HIV-1. Purification and characterization. J Biol Chem 265:21979-21985, 1990.
102. H Kido, Y Yokogoshi, K Sakai, M Tashiro, Y Kishino, A Fukutomi, N Katunuma. Isolation and characterization of a novel trypsin-like protease found in rat bronchio-lar epithelial Clara cells. A possible activator of the viral fusion glycoprotein. J Biol Chem 267:13573-13579, 1992.
103. GW Wong, YZ Tang, RL Stevens. Cloning of the human homolog of mouse transmembrane tryptase. Int Arch Allergy Immunol 118:419-421, 1999.
104. K Sakai, S Ren, LB Schwartz. A novel heparin-dependent processing pathway for human tryptase: autocatalysis followed by activation with dipeptidyl peptidase I. J Clin Invest 97:988-995, 1996.
105. K Sakai, SD Long, DAD Pettit, GA Cabral, LB Schwartz. Expression and purification of recombinant human tryptase in a baculovirus system. Protein Expression Purif 7:67-73, 1996.
106. MA Sherman, VH Secor, SK Lee, RD Lopez, MA Brown. STAT6-independent production of IL-4 by mast cells. Eur J Immunol 29:1235-1242, 1999.
107. LB Schwartz, AMA Irani, K Roller, C Castells, NM Schechter. Quantitation of histamine, tryptase and chymase in dispersed human T and TC mast cells. J Immunol 138:2611-2615, 1987.
108. S Ren, AE Lawson, M Carr, CM Baumgarten, LB Schwartz. Human tryptase fi-brinogenolysis is optimal at acidic pH and generates anticoagulant fragments in the presence of the anti-tryptase monoclonal antibody B12. J Immunol 159:3540-3548, 1997.
109. D Proud, ES Siekierski, GS Bailey. Identification of human lung mast cell kinino-genase as tryptase and relevance of tryptase kininogenase activity. Biochem Pharmacol 37:1473-1480, 1988.
110. S Ren, K Sakai, LB Schwartz. Regulation of human mast cell P-tryptase: conversion of inactive monomer to active tetramer at acid pH. J Immunol 160:4561-4569, 1998.
111. NM Schechter, JE Fraki, JC Geesin, GS Lazarus. Human skin chymotryptic protease. Isolation and relation to cathepsin G and rat mast cell proteinase. J Biol Chem258:2973-2978, 1983.
112. GH Caughey, EH Zerweck, P Vanderslice. Structure, chromosomal assignment, and deduced amino acid sequence of a human gene for mast cell chymase. J Biol Chem 266:12956-12963, 1991.
113. IA Osman, JR Garrett, RE Smith. Enzyme histochemical discrimination between tryptase and chymase in mast cells of human gut. J Histochem Cytochem 37:415-421, 1989.
114. R Huber, W Bode, NM Schechter, S Strobl. The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity. J Mol Biol 286: 163-173, 1999.
115. A Kinoshita, H Urata, FM Bumpus, A Husain. Multiple determinants for the high substrate specificity of an angiotensin II-forming chymase from the human heart. J Biol Chem 266:19192-19197, 1991.
116. M Murakami, SS Karnik, A Husain. Human prochymase activation. A novel role for heparin in zymogen processing. J Biol Chem 270:2218-2223, 1995.
117. G Pejler, JE Sadler. Mechanism by which heparin proteoglycan modulates mast cell chymase activity. Biochemistry 38:12187-12195, 1999.
118. M Walter, RM Sutton, NM Schechter. Highly efficient inhibition of human chy-mase by alpha(2)macroglobulin. Arch Biochem Biophys 368:276-284, 1999.
119. H-Z Xia, CL Kepley, K Sakai, J Chelliah, A-MA Irani, LB Schwartz. Quantitation of tryptase, chymase, FceRIa, and FceRIgamma mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction. J Immunol 154:5472-5480, 1995.
120. NM Schechter, LF Brass, RM Lavker, PJ Jensen. Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts. J Cell Physiol 176:365-373, 1998.
121. CP Sommerhoff, KC Fang, JA Nadel, GH Caughey. Classical second messengers are not involved in proteinase-induced degranulation of airway gland cells. Am J Physiol 271:L796-L803, 1996.
122. BJ Longley, L Tyrrell, YS Ma, DA Williams, R Halaban, K Langley, HS Lu, NM Schechter. Chymase cleavage of stem cell factor yields a bioactive, soluble product. Proc Natl Acad Sci USA 94:9017-9021, 1997.
123. MW Kofford, LB Schwartz, NM Schechter, DR Yager, RF Diegelmann, MF Graham. Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxyl-terminal propeptide. J Biol Chem272:7127-7131, 1997.
124. TC subset with matrix turnover and clinical progression. Arthritis Rheum 40:479-489, 1997.
125. TC type of human mast cell. J Immunol 145:2652-2661, 1990.
126. tc cells. J Immunol 147:247-253, 1991.
127. SM Goldstein, CE Kaempfer, JT Kealey, BU Wintroub. Human mast cell carboxypeptidase: purification and characterization. J Clin Invest 83:1630-1636, 1989.
128. DS Reynolds, DS Gurley, RL Stevens, DJ Sugarbaker, KF Austen, WE Serafin.Cloning of cDNAs that encode human mast cell carboxypeptidase A, and comparison of the protein with mouse mast cell carboxypeptidase A and rat pancreatic carboxypeptidases. Proc Natl Acad Sci USA 86:9480-9484, 1989.
129. C Sillalber, M Baghestanian, D Bevec, M Willheim, H Agis, S Kapiotis, W Fiireder, HC Bankl, HP Kiener, W Speiser, BR Binder, K Lechner, P Valent. The mast cell as site of tissue-type plasminogen activator expression and fibrinolysis. J Immunol162:1032-1041, 1999.
130. N Kanbe, A Tanaka, M Kanbe, A Itakura, M Kurosawa, H Matsuda. Human mast cells produce matrix metalloproteinase 9. Eur J Immunol 29:2645-2649, 1999.
131. KC Fang, PJ Wolters, M Steinhoff, A Bidgol, JL Blount, GH Caughey. Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-P. J Immunol162:5528-5535, 1999.
132. A Tanaka, K Arai, Y Kitamura, H Matsuda. Matrix metalloproteinase-9 production, a newly identified function of mast cell progenitors, is downregulated by c-kit receptor activation. Blood 94:2390-2395, 1999.
133. 2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells. Proc Natl Acad Sci USA 96:4803-4807, 1999.
134. KR Lynch, GP O’Neill, Q Liu, DS Im, N Sawyer, KM Metters, N Coulombe, M Abramovitz, DJ Figueroa, Z Zeng, BM Connolly, C Bai, CP Austin, A Cha-teauneuf, R Stocco, GM Greig, S Kargman, SB Hooks, E Hosfield, DL Williams Jr., AW Ford-Hutchinson, CT Caskey, JF Evans. Characterization of the human cysteinyl leukotriene CysLTl receptor. Nature 399:789-793, 1999.
135. T Colamorea, R Di Paola, F Macchia, MC Guerrese, A Tursi, JH Butterfield, MF Caiaffa, JZ Haeggstrom, L Macchia. 5-lipoxygenase upregulation by dexa-methasone in human mast cells. Biochem Biophys Res Commun 265:617-624, 1999.
136. LJII Roberts, BJ Sweetman, RA Lewis, KF Austen, JA Oates. Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med 303: 1400-1404, 1980.
137. 2 generation via prostaglandin endoperoxide synthase-2. J Immunol 155:4445-4453, 1995.
138. DM Underhill, A Ozinsky, AM Hajjar, A Stevens, CB Wilson, M Bassetti, A Aderem. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401:811-815, 1999.
139. 2 and histamine activate human eosinophils. J Immunol 148:3536-3542, 1992.
140. T Matsuoka, M Hirata, H Tanaka, Y Takahashi, T Murata, K Kabashima, Y Sugi-moto, T Kobayashi, F Ushikubi, Y Aze, N Eguchi, Y Urade, N Yoshida, K Kimura, A Mizoguchi, Y Honda, H Nagai, S Narumiya. Prostaglandin D(2) as a mediator of allergic asthma. Science 287:2013-2017, 2000.
141. M Wang, A Saxon, D Diaz-Sanchez. Early IL-4 production driving Th2 differentiation in a human in vivo allergic model is mast cell derived. Clin Immunol Immuno-pathol 90:47-54, 1999.
142. A-M Irani, KT Nouri-Aria, MR Jacobson, EM Varga, SJ Till, SR Durham, LB Schwartz. Basophil, eosinophil and IL-4 mRNA-positive cell numbers increase in the bronchial mucosa of atopic asthmatics 24 h after segmental bronchial allergen challenge. J Allergy Clin Immunol 105:827-2000.
143. G Devouassoux, B Foster, LM Scott, DD Metcalfe, C Prussin. Frequency and characterization of antigen-specific IL-4- and IL-13- producing basophils and T cells in peripheral blood of healthy and asthmatic subjects. J Allergy Clin Immunol 104: 811-819, 1999.
144. CS Lantz, M Yamaguchi, HC Oettgen, IM Katona, I Miyajima, JP Kinet, SJ Galli.IgE regulates mouse basophil Fce RI expression in vivo. J Immunol 158:2517-2521, 1997.
145. M Yamaguchi, CS Lantz, HC Oettgen, IM Katona, T Fleming, I Miyajima, JP Kinet, SJ Galli. IgE enhances mouse mast cell FceRI expression in vitro and in vivo: Evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med 185:663-672, 1997.
146. D MacGlashan, JT Schroeder. Functional consequences of Fc epsilon RI alpha up-regulation by IgE in human basophils. J Leuk Biol 68:479-486, 2000.
147. M Yamaguchi, K Sayama, K Yano, CS Lantz, N Noben-Trauth, C Ra, JJ Costa, SJ Galli. IgE enhances Fce receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fce receptor I expression and mediator release. J Immunol 162:5455-5465, 1999.
148. K Yano, M Yamaguchi, F De Mora, CS Lantz, JH Butterfield, JJ Costa, SJ Galli.Production of macrophage inflammatory protein-1a by human mast cells: increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast cell IgE-binding ability. Lab Invest 77:185-193, 1997.
149. J-F Gauchat, S Henchoz, G Mazzei, J-P Aubry, T Brunner, H Blasey, P Life, D Talabot, L Flores-Romo, J Thompson, K Kishi, J Butterfield, C Dahinden, J-Y Bonnefoy. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365:340-343, 1993.
150. B Baird, ED Sheets, D Holowka. How does the plasma membrane participate in cellular signaling by receptors for immunoglobulin E? Biophys Chem 82:109-119, 1999.
151. D Dombrowicz, SQ Lin, V Flamand, AT Brini, BH Koller, JP Kinet. Allergy-associated FcRP is a molecular amplifier of IgE- and lgG-mediated in vivo responses. Immunity 8:517-529, 1998.
152. SQ Lin, C Cicala, AM Scharenberg, JP Kinet. The FceRIP subunit functions as an amplifier of FceRIgamma-mediated cell activation signals. Cell 85:985-995, 1996.
153. JM Oliver, DL Burg, BS Wilson, JL McLaughlin, RL Geahlen. Inhibition of mast cell FceR1-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol. J Biol Chem 269:29697-29703, 1994.
154. VM Rivera, JS Brugge. Clustering of Syk is sufficient to induce tyrosine phosphorylation and release of allergic mediators from rat basophilic leukemia cells. Mol Cell Biol 15:1582-1590, 1995.
155. A Valle, J-P Kinet. A-acetyl-L-cysteine inhibits antigen-mediated Syk, but not Lyn tyrosine kinase activation in mast cells. FEBS Lett 357:41-44, 1995.
156. CL Kepley, L Youssef, RP Andrews, BS Wilson, JM Oliver. Syk deficiency in nonreleaser basophils. J Allergy Clin Immunol 104:279-284, 1999.
157. CL Kepley, L Youssef, RP Andrews, BS Wilson, JM Oliver. Multiple defects in Fc epsilon RI signaling in Syk-deficient nonreleaser basophils and IL-3-Induced recovery of Syk expression and secretion. J Immunol 165:5913-5920, 2000.
158. H Lienard, P Bruhns, O Malbec, WH Fridman, M Daeron. Signal regulatory proteins negatively regulate immunoreceptor-dependent cell activation. J Biol Chem274:32493-32499, 1999.
159. SA Berger, TW Mak, CJ Paige. Leukocyte common antigen (CD45) is required for immunoglobulin E-mediated degranulation of mast cells. J Exp Med 180:471-476, 1994.
160. H Suzuki, M Takei, M Yanagida, T Nakahata, T Kawakami, H Fukamachi. Early and late events in FceRI signal transduction in human cultured mast cells. J Immunol 159:5881-5888, 1997.
161. D Hata, Y Kawakami, N Inagaki, CS Lantz, T Kitamura, WN Khan, M Maeda-Yamamoto, T Miura, W Han, SE Hartman, L Yao, H Nagai, AE Goldfeld, FW Alt, SJ Galli, ON Witte, T Kawakami. Involvement of Bruton’s tyrosine kinase in FceRI-dependent mast cell degranulation and cytokine production. J Exp Med 187: 1235-1247, 1998.
162. R Setoguchi, T Kinashi, H Sagara, K Hirosawa, K Takatsu. Defective degranulation and calcium mobilization of bone-marrow derived mast cells from Xid and Btk-deficient mice. Immunol Lett 64:109-118, 1998.
163. VI Pivniouk, TR Martin, JM Lu-Kuo, HR Katz, HC Oettgen, RS Geha. SLP-76 deficiency impairs signaling via the high-affinity IgE receptor in mast cells. J Clin Invest 103:1737-1743, 1999.
164. L Frigeri, JR Apgar. The role of actin microfilaments in the down-regulation of the degranulation response in RBL-2H3 mast cells. J Immunol 162:2243-2250, 1999.
165. R Sullivan, LS Price, A Koffer. Rho controls cortical F-actin disassembly in addition to, but independently of, secretion in mast cells. J Biol Chem 274:38140-38146, 1999.
166. 2+-triggered exocytosis of lysosomes in mast cells. J Exp Med 189:1649-1657, 1999.
167. WR Sperr, HC Bankl, G Mundigler, G Klappacher, K Grossschmidt, H Agis, P Simon, P Laufer, M Imhof, T Radaszkiewicz, D Glogar, K Lechner, P Valent.The human cardiac mast cell: localization, isolation, phenotype, and functional characterization. Blood 84:3876-3884, 1994.
168. M Mousli, TE Hugli, Y Landry, C Bronner. Peptidergic pathway in human skin and rat peritoneal mast cell activation. Immunopharmacology 27:1-11, 1994.
169. M Iikura, M Yamaguchi, M Miyamasu, Y Morita, T Iwase, I Moro, K Yamamoto, K Hirai. Secretory IgA-mediated basophil activation. Biochem Biophys Res Com-mun 264:575-579, 1999.
170. M Iikura, M Yamaguchi, T Fujisawa, M Miyamasu, T Takaishi, Y Morita, T Iwase, I Moro, K Yamamoto, K Hirai. Secretory IgA induces degranulation of IL-3-primed basophils. J Immunol 161:1510-1515, 1998.
171. V Patella, G Florio, A Petraroli, G Marone. HIV-1 gp120 induces IL-4 and IL-13 release from human Fc epsilon RI+ cells through interaction with the V(H)3 region of IgE. J Immunol 164:589-595, 2000.
172. PT Peachell, LM Lichtenstein, RP Schleimer. Differential regulation of human basophil and lung mast cell function by adenosine. J Pharmacol Exp Ther 256:717-726, 1991.
173. 2B adenosine receptor subtypes. Biochem Pharmacol 55:627-633, 1998.
174. ES Schulman, MC Glaum, T Post, YH Wang, DG Raible, J Mohanty, JH Butterfield, A Pelleg. ATP modulates anti-IgE-induced release of histamine from human lung mast cells. Am J Respir Cell Mol Biol 20:530-537, 1999.
175. SM MacDonald, T Rafnar, J Langdon, LM Lichtenstein. Molecular identification of an IgE-dependend histamine-releasing factor. Science 269:688-690, 1995.
176. JT Schroeder, LM Lichtenstein, SM MacDonald. Recombinant histamine-releasing factor enhances IgE-dependent IL-4 and IL-13 secretion by human basophils. J Immunol 159:447-452, 1997.
177. M Baggiolini, M Uguccioni, P Loetscher. Chemokines and chemokine receptors in allergic inflammation. In: G Marone, LM Lichtenstein, KF Austen, ST Holgate, eds. Asthma and Allergic Diseases: Physiology, Immunopharmacology and Treatment. New York: Academic Press, 1998, pp 157-167.
178. M Uguccioni, CR Mackay, B Ochensberger, P Loetscher, S Rhis, GJ LaRosa, P Rao, PD Ponath, M Baggiolini, CA Dahinden. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest 100:1137-1143, 1997.
179. K Hartmann, F Beiglböck, BM Czarnetzki, T Zuberbier. Effect of CC chemokines on mediator release from human skin mast cells and basophils. Int Arch Allergy Immunol 108:224-230, 1995.
180. MD Silverstein, CE Reed, EJ O’Connell, LJ Melton, III, WM O’Fallon, JW Yun-ginger. Long-term survival of a cohort of community residents with asthma. N Engl J Med 331:1537-1541, 1994.
181. M Baghestanian, R Hofbauer, HP Kiener, HC Bankl, F Wimazal, M Willheim, O Scheiner, W Füreder, MR Müller, D Bevec, K Lechner, P Valent. The c-kit ligand stem cell factor and anti-IgE promote expression of monocyte chemoattractant protein-1 in human lung mast cells. Blood 90:4438-4449, 1997.
182. S Imayama, Y Shibata, Y Hori. Epidermal mast cells in atopic dermatitis. Lancet346:1559-1559, 1995.
183. K Rajakulasingam, SR Durham, F O’Brien, M Humbert, LT Barata, L Reece, AB Kay, JA Grant. Enhanced expression of high-affinity IgE receptor (FceRI) a chain in human allergen-induced rhinitis with co-localization to mast cells, macrophages, eosinophils, and dendritic cells. J Allergy Clin Immunol 100:78-86, 1997.
184. CL Kepley, SS Craig, LB Schwartz. Identification and partial characterization of a unique marker for human basophils. J Immunol 154:6548-6555, 1995.
185. AR McEuen, MG Buckley, SJ Compton, AF Walls. Development and characterization of a monoclonal antibody specific for human basophils and the identification of a unique secretory product of basophil activation. Lab Invest 79:27-38, 1999.
186. AM Irani, C Huang, HZ Xia, C Kepley, A Nafie, ED Fouda, S Craig, B Zweiman, LB Schwartz. Immunohistochemical detection of human basophils in late-phase skin reactions. J Allergy Clin Immunol 101:354-362, 1998.
187. S Ying, DS Robinson, Q Meng, LT Barata, AR McEuen, MG Buckley, AF Walls, PW Askenase, AB Kay. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: Association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (Monocyte chemoattractant protein-3 and RANTES). J Immunol 163:3976-3984, 1999.
188. AJ Macfarlane, OM Kon, SJ Smith, K Zeibecoglou, LN Khan, LT Barata, AR McEuen, MG Buckley, AF Walls, Q Meng, M Humbert, NC Barnes, DS Robinson, S Ying, AB Kay. Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late- phase allergic reactions in the lung and skin. J Allergy Clin Immunol 105:99-107, 2000.
189. A KleinJan, AR McEuen, MD Dijkstra, MG Buckley, AF Walls, WJ Fokkens.Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocation. J Allergy Clin Immunol 106:677-686, 2000.
190. DR Wilson, A-M Irani, SM Walker, M Baran, MR Jacobson, LB Schwartz, SR Durham. Grass pollen immunotherapy reduces seasonal increases in epithelial basophils but not mast cells. J Allergy Clin Immunol 105:211-2000.
191. WD Travis, C-Y Li, EJ Bergstralh, LT Yam, RG Swee. Systemic mast cell disease. Analysis of 58 cases and literature review. Medicine (Baltimore) 67:345-368, 1988.
192. DD Metcalfe. Classification and diagnosis of mastocytosis: current status. J Invest Dermatol 96:2S-4S, 1991.
193. LB Schwartz, K Sakai, TR Bradford, SL Ren, B Zweiman, AS Worobec, DD Metcalfe. The α form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest 96:2702-2710, 1995.
194. LB Schwartz, TR Bradford, C Rouse, A-M Irani, G Rasp, JK Van der Zwan, P-WG Van Der Linden. Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J Clin Immunol 14:190-204, 1994.
195. LB Schwartz, DD Metcalfe, JS Miller, H Earl, T Sullivan. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 316:1622-1626, 1987.
196. LB Schwartz, JW Yunginger, JS Miller, R Bokhari, D Dull. The time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 83:1551-1555, 1989.
197. P-WG Van der Linden, CE Hack, J Poortman, YC Vivie-Kipp, A Struyvenberg, JK Van der Zwan. Insect-sting challenge in 138 patients: Relation between clinical severity of anaphylaxis and mast cell activation. J Allergy Clin Immunol 90:110-118, 1992.
198. MK Church, SP Skinner, LJ Burrows, AP Bewley. Microdialysis in human skin. Clin Exp Allergy 25:1027-1029, 1995.
199. H Behrendt, J Ring. Histamine, antihistamines and atopic eczema. Clin Exp Allergy20 (suppl 4):25-30, 1990.
200. M Hannuksela, K Kalimo, K Lammintausta, T Mattila, K Turjanmaa, E Varjonen, PJ Coulie. Dose ranging study: cetirizine in the treatment of atopic dermatitis in adults. Ann Allergy 70:127-133, 1993.
201. T Langeland, HE Fagertun, S Larsen. Therapeutic effect of loratadine on pruritus in patients with atopic dermatitis. A multi-crossover-designed study. Allergy 49: 22-26, 1994.
202. JM Hanifin. The role of antihistamines in atopic dermatitis. J Allergy Clin Immunol86:666-669, 1990.
203. CF Wahlgren. Itch and atopic dermatitis: clinical and experimental studies. Acta Derm Venereol Suppl (Stockh) 165:1-53, 1991.
204. G Heyer, OP Hornstein, HO Handwerker. Skin reactions and itch sensation induced by epicutaneous histamine application in atopic dermatitis and controls. J Invest Dermatol 93:492-496, 1989.
205. A Giannetti, G Girolomoni. Skin reactivity to neuropeptides in atopic dermatitis. Br J Dermatol 121:681-688, 1989.
206. R Rukwied, G Lischetzki, F McGlone, G Heyer, M Schmelz. Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study. Br J Dermatol 142:1114-1120, 2000.
207. AA Irani, G Nilsson, LK Ashman, LB Schwartz. Dexamethasone inhibits the development of mast cells from dispersed human fetal liver cells cultured in the presence of recombinant human stem cell factor. Immunology 84:72-78, 1995.
208. DG Malone, RL Wilder, AM Saavedra-Delgado, DD Metcalfe. Mast cell numbers in rheumatoid synovial tissues. Correlations with quantitative measures of lympho-tic infiltration and modulation by anti-inflammatory therapy. Arthritis Rheum 30: 130-137, 1987.
209. RM Lavker, NM Schechter. Cutaneous mast cell depletion results from topical corticosteroid usage. J Immunol 135:2368-2373, 1985.
210. P Goldsmith, B McGarity, AF Walls, MK Church, GH Millward-Sadler, DAF Robertson. Corticosteroid treatment reduces mast cell numbers in inflammatory bowel disease. Digest Dis Sci 35:1409-1413, 1990.
211. AM Bentley, MR Jacobson, V Cumberworth, JR Barkans, R Moqbel, LB Schwartz, A- MA Irani, AB Kay, SR Durham. Immunohistology of the nasal mucosa in seasonal allergic rhinitis: Increases in activated eosinophils and epithelial mast cells. J Allergy Clin Immunol 89:877-883, 1992.
212. L Enerbäck, U Pipkorn, G Granerus. Intraepithelial migration of nasal mucosal mast cells in hay fever. Int Arch Allergy Appl Immunol 80:44-51, 1986.
213. C Stellato, A De Paulis, A Ciccarelli, R Cirillo, V Patella, V Casolaro, G Marone.Anti-inflammatory effect of cyclosporin A on human skin mast cells. J Invest Dermatol 98:800-804, 1992.
214. R Cirillo, M Triggiani, L Siri, A Ciccarelli, GR Pettit, M Condorelli, G Marone.Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin. J Immunol 144:3891-3897, 1990.
215. G Marone, M Triggiani, R Cirillo, A Giacummo, L Siri, M Condorelli. Cyclosporin A inhibits the release of histamine and peptide leukotriene C4 from human lung mast cells. Ric Clin Lab 18:53-59, 1988.
216. JM Naeyaert, JM Lachapelle, H Degreef, BM de la, M Heenen, J Lambert. Cyclosporin in atopic dermatitis: review of the literature and outline of a Belgian consensus. Dermatology 198:145-152, 1999.
217. T Ruzicka, T Bieber, E Schopf, A Rubins, A Dobozy, JD Bos, S Jablonska, I Ahmed, K Thestrup-Pedersen, F Daniel, A Finzi, S Reitamo. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med 337:816-821, 1997.